Company profile
Purespring Therapeutics
We are Purespring. We are on a mission to radically transform the treatment of kidney diseases.
- Industry
- Biotechnology Research
- Employees
- 58
- Headquarters
- London
- Founded
- 2020
- Office locations
- 1
Purespring Therapeutics company summary
Purespring Therapeutics is a company in the Biotechnology Research industry, headquartered in London, founded in 2020. On LinkedIn the company has around 58 employees. Its listed specialties include biotechnology, gene therapy, kidney diseases.
What technology does Purespring Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Purespring Therapeutics
Purespring, which launched in November 2020 with £45 million of funding from Syncona Ltd, is the first company to be directly targeting the podocyte, a specialized kidney cell implicated in many kidney diseases, through AAV gene therapy. This approach is based on the work of Professor Moin Saleem, Professor of Paediatric Renal Medicine at the University of Bristol, where he heads a world leading group researching glomerular diseases.
Specialties
Where is Purespring Therapeutics located?
Purespring Therapeutics lists 1 location.
Compare companies similar to Purespring Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Purespring Therapeutics purespringtx.com | Biotechnology Research | 58 | 2020 | London |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Purespring Therapeutics
What does Purespring Therapeutics do?
Purespring, which launched in November 2020 with £45 million of funding from Syncona Ltd, is the first company to be directly targeting the podocyte, a specialized kidney cell implicated in many kidney diseases, through AAV gene therapy. This approach is based on the work of Professor Moin Saleem, Professor of Paediatric Renal Medicine at the University of Bristol, where he heads a world leading group researching glomerular diseases.
How many employees does Purespring Therapeutics have?
Purespring Therapeutics has around 58 employees on LinkedIn.
Where is Purespring Therapeutics headquartered?
Purespring Therapeutics is headquartered in London.
When was Purespring Therapeutics founded?
Purespring Therapeutics was founded in 2020.
Build a lead list from companies like Purespring Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.